1,438 results match your criteria: "Australian and New Zealand Intensive Care Research Centre[Affiliation]"
Crit Care
November 2024
Department of Intensive Care, Austin Hospital, Melbourne, Australia.
Dysregulation of the renin-angiotensin-aldosterone-system (RAAS) in sepsis is a complex and early phenomenon with a likely significant contribution to organ failure and patient outcomes. A better understanding of the pathophysiology and intricacies of the RAAS in septic shock has led to the use of exogenous angiotensin II as a new therapeutic agent. In this review, we report a multinational and multi-disciplinary expert panel discussion on the role and implications of RAAS modulation in sepsis and the use of exogenous angiotensin II.
View Article and Find Full Text PDFNEJM Evid
December 2024
Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
J Hum Nutr Diet
February 2025
Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.
J Acad Consult Liaison Psychiatry
November 2024
Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia; Institute of Molecular Bioscience, University of Queensland, Brisbane, Australia; Speech and Language Therapy, The Royal London Hospital, London, United Kingdom.
Intensive Care Med
November 2024
Department of Cardiac Anesthesiology and Intensive Care Medicine, Charité Berlin, Berlin, Germany.
Blood Purif
November 2024
Department of Intensive Care, Austin Hospital, Heidelberg, Victoria, Australia.
Introduction: Paracetamol (acetaminophen)-induced acute liver failure (ALF) with severe hyperammonemia (ammonia >100 µmol⋅L-1) is a life-threatening condition. A strategy based on high-intensity continuous renal replacement therapy (CRRT) without early (up to day seven) transplantation may enable clinicians to safely identify which patients can recover and survive and which patients require transplantation.
Methods: We conducted a single-center, retrospective cohort study of patients with severely hyperammonemic paracetamol-induced ALF.
Resuscitation
December 2024
Regional Intensive Care Unit, Royal Victoria Hospital, 274 Grosvenor Road, Belfast, UK; Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, UK. Electronic address:
Background: In Europe, approximately 291,000 cardiac arrests occur annually. Despite critical care therapy, hospital mortality remains high. This systematic review assessed whether, in comatose survivors of cardiac arrest, any drug therapy, compared to placebo or usual care, improves outcomes.
View Article and Find Full Text PDFJ Intensive Care Soc
November 2024
Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Background: Fluid therapy is universally administered in the management of patients with sepsis, however excessive cumulative fluid balance has been shown to result in worse outcomes. Hyperoncotic albumin results in both lower fluid volumes and early cumulative fluid balance, and may reduce short-term mortality in patients with septic shock.
Methods: In this single centre, open label, feasibility trial; patients with early septic shock will be randomly allocated either 20% albumin for resuscitation and daily supplementation, versus buffered crystalloids alone for all fluid therapy.
Int J Speech Lang Pathol
November 2024
Graduate School of Health, University of Technology Sydney, Sydney, Australia.
Purpose: Pharyngeal residue rating scales are often used to rate pharyngeal residue observed during flexible endoscopic evaluation of swallowing. Despite the widespread use of pharyngeal residue rating scales, there is no data that has systematically explored user experience. The aim of this scoping review was to investigate specific reporting of user experience, user centred design principles, and normative data in the development of pharyngeal residue rating scales.
View Article and Find Full Text PDFAust Crit Care
November 2024
Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; Department of Intensive Care, Austin Hospital, Heidelberg, Australia; Centre for Integrated Critical Care, The University of Melbourne, Melbourne, Australia.
BMC Anesthesiol
November 2024
Intensive Care Research, Austin Hospital and Co-director, Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Melbourne, Australia.
Blood Purif
November 2024
Department of Critical Care, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
Introduction: Hemoadsorption can be used as adjunctive therapy for sepsis. However, there is limited evidence regarding its antibiotic removal. In this in vivo preclinical study, we aimed to evaluate the removal of meropenem and piperacillin with the HA380 hemoadsorption cartridge.
View Article and Find Full Text PDFChest
October 2024
Malcolm Fisher Department of Intensive Care Medicine, Royal North Shore Hospital, St. Leonards, NSW, , Australia; Critical Care Program, The George Institute for Global Health and UNSW, Barangaroo, NSW, Australia; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Australia. Electronic address:
Background: Lower respiratory tract infections are common in patients receiving invasive mechanical ventilation in an ICU after an acute brain injury and may have deleterious consequences.
Research Question: In adults with acute brain injury receiving invasive mechanical ventilation in an ICU, is the administration of prophylactic parenteral antibiotics, compared with placebo or usual care, associated with reduced mortality?
Study Design And Methods: We conducted a systematic review and meta-analysis. We searched for randomized clinical trials (RCTs) in electronic databases, as well as unpublished trials.
J Cardiothorac Vasc Anesth
December 2024
Department of Anaesthesiology and Perioperative Medicine, Alfred Health and Monash University, Melbourne, Victoria, Australia; Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, Victoria, Australia. Electronic address:
Objectives: To assess whether angiotensin II infusion increases pulmonary vascular resistance (PVR) relative to norepinephrine.
Design: Secondary analysis of a double-blinded randomized feasibility study.
Setting: Two tertiary metropolitan hospitals in Melbourne, Australia.
Aust Crit Care
November 2024
Department of Intensive Care, Frankston Hospital, 2 Hastings Road, Frankston, Victoria 3199, Australia; Peninsula Clinical School, Monash University, 2 Hastings Road, Frankston, Victoria 3199, Australia; Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria 3004, Australia; Department of Intensive Care, Dandenong Hospital, Monash Health, 135 David St, Dandenong, Victoria 3175, Australia.
Objectives: Persistent critical illness (PerCI) occurs when the patient's prolonged intensive care unit (ICU) stay results in complications that become the primary drivers of their condition, rather than the initial reason for their admission. Patients with frailty have a higher risk of developing and dying from PerCI. We aimed to investigate the interplay of frailty and PerCI in critically ill patients with COVID-19.
View Article and Find Full Text PDFCurr Opin Clin Nutr Metab Care
October 2024
Department of Critical Care, University of Melbourne.
Purpose Of Review: Acute kidney injury (AKI) is common in hospitalized patients and is independently associated with morbidity and mortality. Moreover, AKI increases the risk of chronic kidney disease, which is a major healthcare problem. Currently, no single therapy has been proven to be effective in preventing AKI.
View Article and Find Full Text PDFCrit Care Med
January 2025
Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA.
J Pediatr Gastroenterol Nutr
January 2025
Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
Trials
October 2024
Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
Background: Australia's clinical trials sector is highly productive with continued sector investment needed to enhance research impact. Generating economic evidence alongside trials has the potential to facilitate the implementation of trial results into practice. Ascertaining the use of health economic evaluations alongside clinical trials can assist in determining whether clinical trials fully realize and operationalize their potential to change policy and practice.
View Article and Find Full Text PDFAnesth Analg
November 2024
Department of Intensive Care, Austin Hospital, Melbourne, Australia, Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.
Intensive Care Med
December 2024
Department of Critical Care, Melbourne Medical School, University of Melbourne, Parkville, VIC, Australia.
J Crit Care
February 2025
Faculty of Medicine, University of Queensland, Mayne Medical School, 20 Weightman St, Brisbane, QLD 4006, Australia; Queensland University of Technology (QUT), 2 George St, Brisbane, QLD 4000, Australia; Intensive Care Unit, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, QLD 4102, Australia. Electronic address:
Purpose: Clinical trials focusing on critically ill patients with metabolic acidosis, a common exclusion criterion is the presence of a PaCO > 45 mmHg. The aim of this study was to assess the impact of mild hypercapnia on patient characteristics, severity, and clinical outcomes in critically ill patients with metabolic acidosis.
Material And Methods: Multicentre, retrospective, observational study conducted in 12 intensive care units (ICUs) in Queensland, Australia.
Intensive Care Med
December 2024
Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.
Crit Care
October 2024
Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy.
Background: The aim of this study was to assess whether hypothermia increased survival and improved functional outcome when compared with normothermia in out-of-hospital cardiac arrest (OHCA) patients with similar characteristics than in previous randomized studies showing benefits for hypothermia.
Methods: Post hoc analysis of a pragmatic, multicenter, randomized clinical trial (TTM-2, NCT02908308). In this analysis, the subset of patients included in the trial who had similar characteristics to patients included in one previous randomized trial and randomized to hypothermia at 33 °C or normothermia (i.
Aust Crit Care
October 2024
Department of Intensive Care, Austin Health, Melbourne, VIC, Australia; Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia; Data Analytics Research and Evaluation Centre, The University of Melbourne and Austin Hospital, Melbourne, VIC, Australia; Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.
Background And Aims: Prone positioning is commonly applied to improve gas exchange in mechanically ventilated patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). Whilst prone positioning is effective, specific complications may arise. We aimed to assess the prevalence of specific complications related to prone positioning in patients mechanically ventilated for COVID-19-related ARDS.
View Article and Find Full Text PDF